Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.

Kim YC, López-Camacho C, Garcia-Larragoiti N, Cano-Mendez A, Hernandez-Flores KG, Domínguez-Alemán CA, Mar MA, Vivanco-Cid H, Viveros-Sandoval ME, Reyes-Sandoval A.

Viruses. 2019 May 1;11(5). pii: E407. doi: 10.3390/v11050407.

2.

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus.

López-Camacho C, Kim YC, Blight J, Lazaro Moreli M, Montoya-Diaz E, T Huiskonen J, Mareike Kümmerer B, Reyes-Sandoval A.

Viruses. 2019 Apr 3;11(4). pii: E322. doi: 10.3390/v11040322.

3.

Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region.

Kim YC, Lopez-Camacho C, Nettleship JE, Rahman N, Hill ML, Silva-Reyes L, Ortiz-Martinez G, Figueroa-Aguilar G, Mar MA, Vivanco-Cid H, Rollier CS, Zitzmann N, Viveros-Sandoval ME, Owens RJ, Reyes-Sandoval A.

Virol J. 2018 Dec 27;15(1):193. doi: 10.1186/s12985-018-1104-6.

4.

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors.

López-Camacho C, Abbink P, Larocca RA, Dejnirattisai W, Boyd M, Badamchi-Zadeh A, Wallace ZR, Doig J, Velazquez RS, Neto RDL, Coelho DF, Kim YC, Donald CL, Owsianka A, De Lorenzo G, Kohl A, Gilbert SC, Dorrell L, Mongkolsapaya J, Patel AH, Screaton GR, Barouch DH, Hill AVS, Reyes-Sandoval A.

Nat Commun. 2018 Jun 22;9(1):2441. doi: 10.1038/s41467-018-04859-5.

5.

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models.

Salman AM, Montoya-Díaz E, West H, Lall A, Atcheson E, Lopez-Camacho C, Ramesar J, Bauza K, Collins KA, Brod F, Reis F, Pappas L, González-Cerón L, Janse CJ, Hill AVS, Khan SM, Reyes-Sandoval A.

Sci Rep. 2017 Apr 18;7:46482. doi: 10.1038/srep46482.

6.

Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites: Naturally Acquired Humoral Immune Response and B-Cell Epitope Mapping in Brazilian Amazon Inhabitants.

Rodrigues-da-Silva RN, Soares IF, Lopez-Camacho C, Martins da Silva JH, Perce-da-Silva DS, Têva A, Ramos Franco AM, Pinheiro FG, Chaves LB, Pratt-Riccio LR, Reyes-Sandoval A, Banic DM, Lima-Junior JD.

Front Immunol. 2017 Feb 7;8:77. doi: 10.3389/fimmu.2017.00077. eCollection 2017.

7.

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine.

Alves E, Salman AM, Leoratti F, Lopez-Camacho C, Viveros-Sandoval ME, Lall A, El-Turabi A, Bachmann MF, Hill AV, Janse CJ, Khan SM, Reyes-Sandoval A.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00501-16. doi: 10.1128/CVI.00501-16. Print 2017 Apr.

8.

CBFβ and the leukemogenic fusion protein CBFβ-SMMHC associate with mitotic chromosomes to epigenetically regulate ribosomal genes.

Lopez-Camacho C, van Wijnen AJ, Lian JB, Stein JL, Stein GS.

J Cell Biochem. 2014 Dec;115(12):2155-64. doi: 10.1002/jcb.24892.

9.

Core binding factor β (CBFβ) is retained in the midbody during cytokinesis.

Lopez-Camacho C, van Wijnen AJ, Lian JB, Stein JL, Stein GS.

J Cell Physiol. 2014 Oct;229(10):1466-74. doi: 10.1002/jcp.24588.

10.

Bookmarking target genes in mitosis: a shared epigenetic trait of phenotypic transcription factors and oncogenes?

Zaidi SK, Grandy RA, Lopez-Camacho C, Montecino M, van Wijnen AJ, Lian JB, Stein JL, Stein GS.

Cancer Res. 2014 Jan 15;74(2):420-5. doi: 10.1158/0008-5472.CAN-13-2837. Epub 2014 Jan 9. Review.

11.

Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription.

Deng W, Lopez-Camacho C, Tang JY, Mendoza-Villanueva D, Maya-Mendoza A, Jackson DA, Shore P.

Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1524-9. doi: 10.1073/pnas.1107879109. Epub 2012 Jan 17.

12.

The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.

Mendoza-Villanueva D, Deng W, Lopez-Camacho C, Shore P.

Mol Cancer. 2010 Jun 30;9:171. doi: 10.1186/1476-4598-9-171.

13.

Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.

Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC.

Blood. 2007 Sep 15;110(6):1916-23. Epub 2007 May 17.

Supplemental Content

Loading ...
Support Center